|
Volumn 28, Issue 3, 2010, Pages 267-268
|
High prevalence of co-expression of newer β-lactamases (ESBLs, Amp-C-β-lactamases, and metallo-β-lactamases) in gram-negative bacilli
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AZTREONAM;
BETA LACTAMASE AMPC;
CARBAPENEM;
CEFEPIME;
CEFOPERAZONE;
CEFOTAXIME;
CEFTAZIDIME;
CIPROFLOXACIN;
CLAVULANIC ACID;
EDETIC ACID;
EXTENDED SPECTRUM BETA LACTAMASE;
GENTAMICIN;
METALLO BETA LACTAMASE;
ANTIINFECTIVE AGENT;
BETA LACTAM;
BETA LACTAMASE;
ACINETOBACTER BAUMANNII;
ACINETOBACTER CALCOACETICUS;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BLOOD;
BODY FLUID;
BURKHOLDERIA CEPACIA COMPLEX;
CEREBROSPINAL FLUID;
ENTEROBACTER AEROGENES;
ESCHERICHIA COLI;
GRAM NEGATIVE BACTERIUM;
KLEBSIELLA PNEUMONIAE;
LETTER;
LUNG LAVAGE;
MORGANELLA MORGANII;
NONHUMAN;
PLASMID;
PROTEIN EXPRESSION;
PROTEUS MIRABILIS;
PROTEUS VULGARIS;
PSEUDOMONAS AERUGINOSA;
PUS;
SEROPREVALENCE;
BIOSYNTHESIS;
ENZYMOLOGY;
GENETICS;
GRAM NEGATIVE INFECTION;
HUMAN;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
PREVALENCE;
ANTI-BACTERIAL AGENTS;
BETA-LACTAM RESISTANCE;
BETA-LACTAMASES;
BETA-LACTAMS;
GRAM-NEGATIVE BACTERIA;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
HUMANS;
PREVALENCE;
|
EID: 77955120431
PISSN: 02550857
EISSN: 19983646
Source Type: Journal
DOI: 10.4103/0255-0857.66479 Document Type: Letter |
Times cited : (6)
|
References (6)
|